openPR Logo
Press release

Metaxalone Market Size Estimated to Reach $5,770 Million by 2026

06-21-2021 10:21 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: IndustryARC

Metaxalone Market

Metaxalone Market

Metaxalone Market size is estimated to reach $5,770 million by 2026, growing at a CAGR of 6% during 2021-2026 forecast period. Metaxalone is a muscle relaxant medication that is administered orally and is used to reduce pain and relax muscles which is caused by strain and other musculoskeletal conditions. Metaxalone works by blocking nerve impulses in the brain and is used as muscle relaxation method. Metaxalone is also called skelaxin which is used for muscle spasms and musculoskeletal pain. Metaxalone is also a mixture of two enantiomers such as R- metaxalone and X-metaxalone which is approved by the Food and Drug Administration (FDA).

The chemical name of metaxalone is oxazolidinone which acts in the central nervous system to produce the muscle relaxant effects. Growing number of musculoskeletal disorders among people and growing number of road accidents is the major factor driving the growth of this market. Furthermore, increasing research and development activities regarding drugs and rising geriatric population is set to further enhance the overall market demand for Metaxalone Market for the period 2021-2026.

Full Report Link @ https://www.industryarc.com/Research/Metaxalone-Market-Research-507036

Metaxalone Segment Analysis – By Indication

The global Metaxalone Market based on Indication can be further segmented into Bone Pain, Muscle Pain, Tunnel Syndrome, Joint Pain, and Others. The Bone Pain segment is the major segment generating revenue in 2020. This is owing to increasing cases of arthritis owing to unhealthy lifestyle. Moreover, increasing outdoor activities increases the demand of metaxalone. The Muscle Pain segment is estimated to register the fastest CAGR of 2.5% for the period 2021-2026. Metaxalone is considered as muscle relaxant which is used to reduce musculoskeletal pain and hence the growth of the segment is rising.

Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=507036
Report Price: $ 5900 (Single User License)

Metaxalone Segment Analysis – By End-Use Industry

The global Metaxalone Market based on End-Use Industry can be further segmented into Hospitals, Clinics, and Others. The Hospital segment registers for the Metaxalone highest market share in 2020. This is owing to easy accessibility of hospital and higher selling capacity. Moreover, owing to the availability of skilled professionals, patients can prefer hospitals and are rising the growth of this segment. The Clinics segment is estimated to register the fastest CAGR of 1.5% over 2021-2026. This is mainly owing to clinics that are opened for more time increasing the selling capacity and also provide fast service which increases the demand of metaxalone and leading to market growth.

Metaxalone Segment Analysis – By Geography

North America dominated the Metaxalone Market with major share of 40% in 2020. This is owing to presence of advanced healthcare system and rising development in pharmaceutical industry. According to American Hospital Association, in 2019 about 6,090 hospitals are identified that focus on the development in healthcare system and are leading to the rising the growth of this segment. However, Asia Pacific is estimated to outpace all the regions by clocking the highest CAGR of 2% during the forecast period 2021-2026 owing to rising population and increasing development in healthcare.

Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=507036

Metaxalone Market Drivers

Growing Number of Musculoskeletal Disorders

Growing number of patients associated with musculoskeletal disorders such as arthritis increases the growth of the Metaxalone Market. According to World Health Organization, about 1.71 billion people may have musculoskeletal conditions in 2021 that increases the demand of metaxalone market. Moreover, increasing number of incidents resulting in injury and growing number of athlete gym is rising the demand of treatment and are increasing the growth of the Metaxalone Market over 2021-2026.

Growing Number of Road Accidents

Rising number of road accidents owing to lack of adequate facilities increases the growth of the Metaxalone Market. According to World Health Organization, about 1.35 million are injured owing to road accidents in 2020 that increases the use of oxazolidinone for the treatment of pain and are increases the growth of Metaxalone Market over 2021-2026.

Covid-19 Impact:

COVID-19 pandemic had greatly affected the Metaxalone Market. Owing to pandemic, there is lockdown that reduces the vehicles on the road which reduces accidents that hamper the growth of this market. Moreover, reduction of numerous outdoor activities including sports and gymnasiums has significantly impacted demand for metaxalone as it provides muscle relaxation and are negatively impacted the growth of this market.

Metaxalone Market Challenges

Increasing Side Effects

The factors that is set to impede the growth of the Metaxalone Market are increasing side effects such as vomiting, headache, nausea, and irritability etc. Moreover, stringent government approval is set to create hurdles for the Metaxalone Market.

Metaxalone Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Metaxalone Market. Metaxalone top 10 companies include, Biosynth, Chunghwa Chemical Synthesis & Biotech Co., Ltd., Sigma-Aldrich Co. LLC, CDI Technology, Angelini S.p.A., Pfizer Inc., Aurum Pharmatech LLC, Finetech Industry Limited, Biocore, and Oxchem Corporation.

Developments

In 30 July 2019, Chunghwa Chemical Synthesis & Biotech Co., Ltd is working on the development of metaxalone in order to reduce musculoskeletal pain and are rising the growth of this market.

Key Takeaways

Geographically, in 2020, North America dominated the Metaxalone Market owing to presence of advanced healthcare system and rising development in pharmaceutical industry.

Growing number of musculoskeletal disorders among people and growing number of road accidents are likely to aid in the market growth of the Metaxalone.

Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Metaxalone Market report.

Increasing side effects is set to create hurdles for the Metaxalone Market.

Related Reports :

A. Musculoskeletal Diseases Market
https://www.industryarc.com/Report/16117/musculoskeletal-diseases-market.html

B. Topical Pain Relief Market
https://www.industryarc.com/Research/Topical-Pain-Relief-Market-Research-502193
For more Lifesciences and Healthcare Market reports, please click here

For more Lifesciences and Healthcare Market reports @ https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Venkat Reddy
Sales Director
Email: venkat@industryarc.com
Website: https://www.industryarc.com
Phone: (+1) 970-236-3677

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metaxalone Market Size Estimated to Reach $5,770 Million by 2026 here

News-ID: 2309585 • Views: 189

More Releases from IndustryARC

Professional Diagnostics Market Size to Grow at a CAGR of 6.3% During the Foreca …
Professional Diagnostics Market size in 2020 is estimated to be $45 billion, growing at a CAGR of 6.3% during the forecast period 2021-2026. Professional diagnostic is the diagnostic method which are used for faster detection of various diseases such as tuberculosis, cancer, malaria, and others. The main purpose of professional diagnostics is to diagnose or monitor disease in early condition so that treatment can be started so that this diagnostic
Body Dryer Market Size to Grow at a CAGR of 6.0% During the Forecast Period 2021 …
Body Dryer Market size was valued at $2,978 million in 2020 and is anticipated to reach $5,143 million by the end of 2026 growing at a CAGR of 6.0% during the forecast period 2021-2026. The Body Dryer industry growth rate is attributed to the rising need to reduce medication errors and development of automated systems with improved features and is likely to new opportunities. Body dryers are type of air
India P2P Lending Market Size Forecast to Reach $10.5 Billion by 2026
The India P2P lending Market size is forecast to reach $10.5 billion by 2026, after growing at a CAGR of 21.6% during the forecast period 2021-2026. The Peer to Peer Lending Market growth is attributed to increasing transparency in P2P lending with technologies such as block chain and smart contracts being incorporated into lending platforms. The Indian Government’s enthusiastic promotion of cashless technologies has also managed to restructure the financial
Cloud Relational Database Market Forecast to Reach $18.8 Billion by 2026
Cloud Relational Database Market is forecast to reach $18.8 billion by 2026, after growing at a CAGR of 38.4% during 2021-2026. With rise in the adoption of IoT technologies and the usage of cloud database for computing in various organizations for different applications is analyzed to boost the Cloud Relational Database Market. Moreover, the cloud databases provide the customers with improved performance, service resilience and so on, thereby enhancing the

All 5 Releases


More Releases for Metaxalone

Global Muscle Relaxant Drug Market Growth, Size, Share, Industry Report and Fore …
The global muscle relaxant drug market is projected to grow at a significant CAGR during the forecast period. The key factors that drive the global market growth include the rising number of geriatric populations, increased number of surgeries, approvals of new label indications, and rapid innovations. Baclofen, dantrolene, and tizanidine are among the three muscle relaxants approved by the FDA to treat spasticity. Whereas, methocarbamol, metaxalone, carisoprodol, chlorzoxazone cyclobenzaprine, and
COVID-19 is Impact on Metaxalone Market Top Companies Analysis To Grow Your Busi …
According to a new report published by Allied Market Research, titled, "Metaxalone Market by Indication (Bone Pain, Muscle Pain, Joint Pain, Tunnel Syndromes, and Others) - Global Opportunity Analysis and Industry Forecast, 2020-2027" The report has offered an all-inclusive analysis of the global Metaxalone Market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the start, the report
Metaxalone Market, Business Will Grow in 2027, Prominent Players: Biosynth, Chun …
According to a new report published by Allied Market Research, titled, "Metaxalone Market by Indication (Bone Pain, Muscle Pain, Joint Pain, Tunnel Syndromes, and Others) - Global Opportunity Analysis and Industry Forecast, 2020-2027". Metaxalone is a white, odourless crystalline powder used to relax muscles and relieve pain that could have occurred due to strain, sprain, and other musculoskeletal conditions. It has sedative and skeletal muscle relaxant effect on the body and
Muscle Relaxant Drugs Market Growth Opportunities and Country Level Segments, Sh …
The global muscle relaxant drugs market is expected to grow with a CAGR of 5.5% during 2015 - 2020.The global muscle relaxant drugs market is growing, due to increasing aging population, increasing incidences of skin diseases and harmful effects of ultra violet radiation. In addition, the increasing usage of neuromuscular blocking agents in surgeries, and increase in disposable income are also driving the growth of the global muscle relaxant drugs
Metaxalone Market Key Players : Biosynth, Chunghwa Chemical Synthesis & Biotech …
Metaxalone is a white, odourless crystalline powder used to relax muscles and relieve pain that could have occurred due to strain, sprain, and other musculoskeletal conditions. It has sedative and skeletal muscle relaxant effect on the body and helps relieve pain. The compound is freely soluble in chloroform; however insoluble in ether or water. Comprehensive competitive analysis and profiles of major market players such as Biosynth, Chunghwa Chemical Synthesis & Biotech
Metaxalone Market to See Incredible Growth By 2017-2022
Qyresearchreports include new market research report Global Metaxalone Sales Market Report 2017 to its huge collection of research reports. Global Metaxalone Market Research Report studies the growth behavior of the global Metaxalone market, looking into demand drivers, opportunities, and competitive outlook over the 2017-2022 period. The report provides a 360 degree overview of the market, beginning with terms and terminologies, conventions, and notations before progressing into applications, classifications, and technological framework